R-Sphere标记免疫分析平台的建立及其对血清中氯胺酮与吗啡的快速联合定量检测
本研究基于Raman微球(R-Sphere)光谱特性与竞争免疫原理,开发了可同时检测血清中氯胺酮(KET)和吗啡(MOP)的试纸条。KET和MOP分别在0.0-100.0 ng/mL和0.0-4.0 ng/mL范围内与Raman信号响应值呈良好相关性,检测限分别为1.1986 ng/mL和0.0113 ng/mL,CV小于10%,回收率90%-110%,干扰物无影响。该方法操作简单、快速、灵敏度高,可联合检测,显著提高检测效率。
要点
- 基于Raman微球与竞争免疫原理的试纸条可同时定量检测血清KET和MOP。
- KET检测限1.1986 ng/mL,MOP检测限0.0113 ng/mL,CV小于10%。
- 该方法操作简单快速、灵敏度高,适合多种场景的联合检测。
核心结论
- 基于Raman微球光谱特性和竞争免疫原理的试纸条可快速联合定量检测血清中KET和MOP,具有操作简单、快速、灵敏度高和联合检测的优势。
研究设计与样本
- 研究将Raman微球标记的KET和MOP抗体混合物与KET和MOP混合标准溶液混合,滴加至制备的KET和MOP联合检测试纸条样品垫,层析10分钟后用Raman光谱仪检测T线Raman光谱和信号。
主要发现
- KET和MOP分别在0.0-100.0 ng/mL和0.0-4.0 ng/mL浓度范围内与Raman信号响应值呈良好相关性。
- KET和MOP的检测限分别为1.1986 ng/mL和0.0113 ng/mL,变异系数(CV)小于10%,回收率范围为90%-110%。
- 干扰物质对检测结果无影响。
关键数值与推荐
- KET线性范围0.0-100.0 ng/mL,MOP线性范围0.0-4.0 ng/mL。
- KET检测限1.1986 ng/mL,MOP检测限0.0113 ng/mL。
- CV小于10%,回收率90%-110%。
临床怎么用
- 该试纸条可用于血清中KET和MOP的快速联合定量检测,适用于药物滥用监测的多种应用场景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Ketamine and morphine are among the most commonly abused drugs. Ketamine is classified as a new psychoactive substance, while morphine represents the opioid class. These two substances may exhibit synergistic or antagonistic effects in their pharmacological actions, and their combined abuse could lead to more severe health risks, such as respiratory depression. Therefore, simultaneous detection is crucial for comprehensive monitoring of drug abuse. This study developed a test strip capable of detecting both ketamine (KET) and morphine (MOP) in serum, utilizing Raman spectroscopy technology to meet the needs of various application scenarios. METHODS: A mixture of Raman microsphere-labelled KET and MOP antibodies was mixed with a mixed standard solution of KET and MOP and added dropwise to the sample pad of the prepared KET and MOP co-assay test strip, chromatographed for 10 min, and then the Raman spectra and Raman signals at the T-line were detected using a Raman spectrometer. RESULTS: The KET and MOP showed good correlation with the Raman signal response values in the concentration ranges of 0.0-100.0 ng/mL and 0.0-4.0 ng/mL, and the limits of detection (LODs) were 1.1986 ng/mL and 0.0113 ng/mL with the coefficients of variation (CV) of less than 10 %, the recoveries were in the ranges of 90 %-110 %, and interfering substances had no effect on the detection results. CONCLUSION: In this study, we developed a method for the quantitative detection of KET and MOP based on the spectroscopic properties of Raman microsphere (R-Sphere) and the principle of competitive immunity, which has the advantages of simple operation, rapidity, high sensitivity, and the possibility of combined detection, which makes the detection efficiency greatly improved.
引用
- Zhao B, Zhu A, Zhang Q, et al. Establishment of a R-Sphere labelled immunoassay platform and its rapid combined quantitative detection of ketamine and morphine in serum. Clin Chim Acta. 2025. PMID: 40056949. doi:10.1016/j.cca.2025.120225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。